days starting from cycle day 2. It was increased to 225 IU in view of poor follicular growth. Later, as the patient developed five follicles >14 mm and six follicles of size 10-14mm, they were counseled regarding switchover to IVF. After 22 days of stimulation and a total HMG dose of 4575 IU, hCG 10000 IU was given for final oocyte maturation. Endometrial thickness (ET) was 13mm and serum estradiol (E2) was 2660 pg/ml on the day of hCG. Eight oocytes were retrieved, five embryos were formed and two 8-celled embryos were transferred on day3. However, she did not conceive in that cycle. After 6 months, frozen embryo transfer (FET) was done. Two good quality embryos were transferred after endometrial preparation with estradiol valerate (6mg daily) and vaginal progesterone (600mg for 3 days prior to embryo transfer). Luteal support with estrogen-progesterone was continued till 12 weeks of gestation. A viable single intrauterine fetus was confirmed on ultrasound at 7 weeks and a healthy baby was born at term.
Case 2
A patient of KS, diagnosed at the age of 20, presented to our clinic at 30 years with primary infertility. She was on HT for the past ten years. Her FSH, LH and E2 were very low and ultrasound showed uterine size of 20x29x58mm and small ovaries (Vol-2.1cc and 2.4cc). She underwent ovulation induction with HMG 225IU from day 2 to day 15 resulting in two follicles≥14mm and was advised timed intercourse after confirmation of ovulation. Luteal support of estrogen and progesterone was continued till 12 weeks after confirmation of pregnancy. She also delivered a healthy baby at term.
Case 3
A 31-year female with BMI 17.2 kg/m2 came with infertility and anosmia. She had withdrawal bleeding only following estrogen progesterone combination. Pelvic examination was normal. Her basal FSH, LH and E2 were 0.91 IU/l, 0.07IU/l and 9.8pg/ml respectively. USG revealed hypoplastic uterus (20x24x48mm) and bilateral small ovaries (Vol 1.3cc and 1.5cc). CT scan of brain, karyotype were normal and KALL-1 gene was present. She was also diagnosed with KS. Other causes of infertility were ruled out. She had poor ET (5mm) even after 12mg of estrogen therapy till day 21. Couple was counseled regarding small sized uterus and poor endometrial response to estrogen. After six months of priming with estrogen-progesterone, ovarian stimulation was started. A dose of 150IU HMG for five days resulted only in 4 follicles of <10mm. This was followed by 225IU HMG for 19 days leading to five follicles of >14mm and three follicles of <14mm. Six oocytes were retrieved and ET was 7.1mm on day of retrieval. Five embryos were formed and two cleavage-stage embryos were transferred. Her βhCG after 14 days of embryo transfer was 52 IU but eventually led to a miscarriage. Endometrial preparation of the patient was attempted three times with high dose estrogen for FET but endometrium never crossed 5mm when observed till day 30. Since surrogacy was not acceptable to the couple, they were counseled for second ovum pick up considering previous optimum endometrial thickness after ovarian stimulation. She was given HT for one year followed by ovarian stimulation with 225IU daily dose of HMG for 17 days. Total 7 follicles of >14mm developed, 6 oocytes were retrieved and ET was 7.3mm on the day of ovum pickup. Two good quality blastocysts were transferred. She again conceived but ended up in missed abortion
DISCUSSION
In patients with KS, the key aim, after diagnosis, is to induce and maintain secondary sexual characteristics by hormone therapy. Once these patients attempt to conceive, they require induction with gonadotropin in high dosages and for prolonged duration. Various ovulation induction protocols have been attempted for infertile women with this syndrome, such as using pulsatile GnRH, combination of recombinant FSH and LH, or HMG. 2 In KS patients, approximately 120 pregnancies have been reported in the literature since 1990. 3 Most commonly used protocol for ovulation induction in women with KS is HMG. 4, 5 In the above case series, all three patients with KS achieved pregnancy with HMG induction. One patient achieved pregnancy with ovulation induction, second with fresh embryo transfer and the third with frozen embryo transfer. Out of the three, two delivered at term and both children were doing well at one year of follow up. Both these successful outcome patients received cyclical hormone therapy since adolescence. Their ovaries responded satisfactorily to gonadotropins and the uterus was well responsive to estrogen therapy. These two patients were diagnosed with KS during their pubertal years and were on hormone therapy since then. The third patient was diagnosed with Kallmann syndrome at 31 years and HT was given only for six months for priming before starting ovulation induction. Since her uterine size was very small (20x24x48mm), growth of endometrial thickness was monitored with incremental doses of estrogen. Endometrial thickness was only 5 mm in spite of high dose of estrogen and guarded prognosis was explained to the couple. During ovarian stimulation with high dose gonadotropins, her endometrial thickness increased to 7.1 mm. She conceived after embryo transfer but unfortunately had a missed abortion. After managing these three cases, we extrapolated that it is important to treat these women with hormone therapy from puberty onwards, not only to attain secondary sexual characteristics but also for satisfactory fertility outcome. In another case series, the author reported that follicular response to gonadotropins was insufficient in patients not previously primed with hormone therapy in comparison to hormone primed patients. 5 Ovulation induction and conception can be achieved sooner and with less cost if they are previously primed.
